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Abstract
Background: It has been suggested that severity of the immune response induced by immune cells is associated
with morbidity and mortality from acute pancreatitis. The authors investigated and evaluated the relationship
between distinct peripheral lymphocyte subsets at admission and clinical outcome prior to hospital discharge so as
to find a predictor to the prognosis of acute pancreatitis in lymphocyte profile.
Methods: Lymphocyte subsets in admission peripheral venous blood were tested through flow cytometry on 48
patients with acute pancreatitis. Clinical data was recorded as well. The primary observational outcomes were
multiple organ failure (MOF) and infection.
Results: There was a significant difference in natural killer cells between two subgroups sorted by the presence or
absence of infection (25.5 ± 4.47 [95% CI 14.4, 36.6] vs 14.8 ± 7.62 [95% CI 12.5,1 7.1] p = 0.021). Patients who
developed MOF had lower CD4 + CD25 + CD127high (4.49 ± 1.5 (MOF) [95% CI 3.83, 5.16] vs 6.57 ± 2.65 (non-MOF)
[95% CI 5.5, 7.64] p = 0.002) and higher CD127low/high cell counts (1.35 ± 0.66 [95% CI 1.06, 1.65] vs 0.97 ± 0.44
[95% CI 0.79, 1.15] p = 0.02). MOF patients were significantly older (55 ± 14.58 [95% CI 48.49,61.42] vs 46 ± 15.59
[95% CI 39.39,51.99] p = 0.04), and had higher Acute Physiology and Chronic Health Evaluation IIscores (7 ± 3.66
[95% CI 5.5,7.64] vs 4 ± 2.89 [95% CI 2.45,4.78] p = 0.001) and C reactive protein (100.53 ± 94.38 [95% CI 58.69,142.48] vs
50.8 ± 59.2 [95% CI 26.88,74.71] p = 0.04). In a multivariate regression model, only CD4 + CD25 + CD127high cell was a
significant predictor of non-MOF. For the detection of non-MOF, CD4 + CD25 + CD127high cell generated a receiver
operating characteristic (ROC) curve with an area under the curve of 0.74.
Conclusion: CD4 + CD25 + CD127high cell at early phase of acute pancreatitis yields good specificity in detecting
non-MOF at a suggested cutoff value 6.41%. Patients with fewer natural killer cells may be at risk in developing
secondary infection.
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Background
Acute pancreatitis (AP) is an inflammatory disorder as-
sociated with high morbidity and mortality rate. The an-
nual incidence of acute pancreatitis ranges from 13 to 45
per 100 000 people [1]. AP is the leading discharge diag-
nosis in patients admitted with gastrointestinal or liver
problems in countries such as the United States [2].
Prognosis of the disease varies widely, from self-limiting
to severe or critical, and mortality reaches 30% in severe
cases [3].
Irrespective of the etiology of pancreatitis, early patho-
physiology events include activation of digestive enzymes
by lysosomal hydrolases, autodigestive processes, intra-
parenchymal inflammatory response and the systemic
inflammatory response syndrome (SIRS). The initial pro-
tease cascade doesn’t necessarily determine the severity
of AP [4]. In contrast, evidence is accumulating of a cru-
cial relationship between innate immune components
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involved in AP pathogenesis and disease severity [5–7].
Neutrophils and macrophages are the first line of the
immune system’s defense. T-lymphocytes, which are
mainly involved in the cell-mediated immune response,
also play a vital role in AP [5]. CD4 + T cells increase the
severity of AP due to macrophage activation via antigen
presentation and pro-inflammatory cytokine release as
well as through direct cytotoxicity effects [5]. Immuno-
logical suppression mediated by regulatory T cells (Tregs)
expressing transcription factor forkhead box P3 (FOXP3)
has been reported to be the critical mechanism controlling
the inflammatory response for which the immune system
is primed after serious injury such as severe AP (SAP) [8].
However, these studies focused on a single lymphocyte
subgroup rather than the broad subgroups of lymphocyte
in patients with AP.
In present study, we evaluated the relationship between
multiple peripheral lymphocyte subsets (i.e., T lymphocyte
cells, T Helper cells, cytotoxic T cells, Tregs, activated
effector T cells, natural killer (NK) cells and B cells)
through flow cytometry done early during hospitalization
vs. patient outcome. We then compared the accuracy of
activated effector T cells estimation to predict non-MOF
with Acute Physiology and Chronic Health Evaluation
(APACHE) IIscores and C reactive protein (CRP) estima-
tion of MOF.
Methods
This prospective clinical observational study was per-
formed between June 2015 and August 2015 in the second
affiliated hospital of Anhui Medicine University. The study
was approved by the hospital’s Ethics Committee. Written
informed consent was obtained from patient surrogates
before study inclusion.
Eligible criteria and treatment
Patients who achieved two of the following three features
were diagnosed as having AP and screened for participa-
tion in the study: acute epigastric pain with or without ra-
diation through to the back; serum amylase or lipase
activity greater than three times the upper limit of normal;
and characteristic features on cross-sectional abdominal
computer tomography (CT) imaging consistent with the
diagnosis of acute pancreatitis [9].Exclusion criteria were:
age <18 or >80 years, previous or chronic treatment with
immunological suppressants such as cortisone or its an-
alogues, immunodeficiency diseases such as acquired
immune deficiency syndrome (AIDS), malignant tumor,
ongoing radiotherapy or chemotherapy, pregnancy, or
patients without written permission or complete data.
Of the 60 cases identified, 48 patients were eligible for
inclusion in the study. Among 12 patients who were ex-
cluded from the study, 8 patients exceeded the study
age limit, 2 patients were pregnant, 1 patient persisted
in taking glucocorticoid due to rheumatoid arthritis,
and the last one was undergoing chemotherapy after
radical gastrectomy.
Eligible patients were included as soon as possible at
time of hospital admission. All patients were treated
according to standard guidelines including fluid resus-
citation, enteral nutrition, endoscopic retrograde cholangio-
pancreatography (ERCP), catheter drainage (Fig. 1) and
necrosectomy when indicated [10].
Sample collection and preparation
Each patient’s peripheral venous blood (2 ml) was collected
in an anticoagulation tube containing heparin within two
hours of admission. Heparin (100ul) was added to each
blood sample in 2 tubes separately. Next, 10ul of mixed
antibodies was added to one of the tubes. A second control
tube was mixed with 10ul Isotype Control Antibodies. The
tubes were mixed gently and incubated for 15 min in the
dark. A hemolytic agent (0.83% NH4Cl) was put in 2 tubes
and incubated for 10 mins in a 37 °C water bath.
Flow cytometry analysis
Lymphocyte subsets in blood were phenotyped by flow
cytometry (Beckman-Coulter, Brea, CA) according to the
manufacturer’s instructions. We first gated on lympho-
cytes based on forward scatter and side scatter; >10,000
cells within gate were obtained for every sample. Each
antibody was matched with a respective isotype IgG1 as a
control, and the gating threshold was set accordingly.
Cells were labeled with specific mono-antibodies in differ-
ent combinations. Lymphocyte subsets were selected for
detailed phenotypic analysis as follows: T lymphocyte cells
were CD3+ T cells; T Helper cells were CD3 +CD4+ T
cells; cytotoxic T cells were CD3 + CD8+ T cells; NK cells
were CD3-CD16 + CD56+ T cells; B cells were CD19 +
CD20 +CD45+ T cells; Tregs were CD4 + CD25 +
CD127low T cells; and activated effector T cells were
CD4 + CD25 + CD127high T cells. Representative gating
figures are shown in Fig. 2.
Endpoints and outcome assessment
The primary observational endpoints of the study were
MOF and infection. Severity of AP was divided into three
categories: mild, moderate severity (MSAP), and severe
(SAP) according to the new revised Atlanta consensus.
Organ failure was defined as a Sepsis-related Organ
Failure Assessment (SOFA) score ≥2. MOF was defined
as failure of two or more organs [11]. Infection was di-
agnosed based on ongoing signs of sepsis and/or the
combination of clinical signs and CT imaging when
extra-luminal gas was present within areas of necrosis
in the pancreatic and/or peri-pancreatic tissues (Fig. 1).
Balthazar scores were used to assess the extent of local
inflammatory changes [1]. Second study endpoints were
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Fig. 1 A 28-year-old man with acute necrotizing pancreatitis complicated by infected pancreatic necrosis requiring multiple percutaneous catheter
drainage (red arrow in A and B). There is a large heterogeneous area of necrosis in the pancreatic and peri-pancreatic area with impacted gas bubbles
(yellow ring in B)
Fig. 2 Gating strategy of peripheral lymphocyte population (a) Gating strategy for CD4+ T cell subdivided into CD4 + CD25 + CD127low and CD4 +
CD25 + CD127high subpopulation. B indicate lymphocyte divided from leukocyte based on forward scatter and side scatter, K indicate CD4+ T cells, G2
indicate CD4 + CD25 + CD127high cells and G4 CD4 + CD25 + CD127low cells. b Gating strategy for lymphocyte subdivided into T Helper cells, cytotoxic
T cells and NK cells subpopulation. H indicate CD3+ T cells, F2 indicate CD3 + CD4+ T cells and J2 CD3 + CD8+ T cells, E1 indicate CD3-CD16 + CD56+
cells which were divided from CD3- T cells. c Gating strategy for B cells. C indicate lymphocyte divided from leukocyte according to CD45 and side
scatter. D2 indicate CD19 + CD20 + CD45+ cells
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mortality before discharge and intensive care unit
(ICU) length of stay (LOS).
We recorded demographic data, comorbid, clinical la-
boratory values, treatment procedure and outcome and
calculated the APACHE II score, SOFA score and Baltha-
zar score in the first 24 h after admission. All data were
entered into a secure and pre-established case report form
by trained research assistants.
Statistical analysis
The study population was characterized using descriptive
statistics. Categorical variables are provided as counts with
frequencies and continuous variables as means with stand-
ard deviations (SD) or medians with quartiles depending
on the normality of the data. Kolmgorov-Smirnov test was
used to test the normal distribution of the data.
Group comparisons used the Student t-test for continu-
ous variables, Chi-square for categorical data, and the
ANOVA test and Mann–Whitney test for ordinal data.
Spearman correlation analysis was used to determine the
degree of relationship between lymphocytes substrate and
other laboratory values and scores. Binary logistic regres-
sion was used for multivariate analysis. Only variables
which were significantly associated with primary outcomes
(including MOF and infection in univariate analysis) were
introduced into the multivariate logistic model. Receiving
operator characteristic (ROC) curves were generated with
corresponding area under curve (AUC) analysis and com-
putation of 95% confidence intervals (CI). The AUC was
calculated as a measure of the ability for each marker to
distinguish between groups. The optimum predictor cut-off
was calculated as a trade-off between sensitivity and specifi-
city. All hypothesis tests were two-sided, with a significance
level of p < 0.05. Statistical analyses were performed using
SPSS version 19.0 (IBM, Chicago, IL).
Results
Patient characteristics
The study included 48 patients. No patients were lost to
follow up and no included patients had incomplete clin-
ical data. The mean age for the complete study popula-
tion was 50 (SD: 16) years and 26 (54%) were male.
Gallstones were the major cause of AP with an incidence
of 39.6%. Baseline patient characteristics including la-
boratory tests at admission are presented in Table 1.
Three (6.25%) patients developed infection and presented
with sepsis and pancreatic abscess (Fig. 1). All recovered
fully after receiving appropriate antibiotics and multiple
percutaneous, CT-guided external drainages (Fig. 1). All
abscess pathogens were confirmed Gram-negative bacteria
including Escherichia coli and Enterococcus faecium.
Twenty-two patients (45.8%) developed subsequent MOF.
One of these patients (2%) died before hospital discharge.
Median hospital LOS was 10 days.
Univariate analysis
Patients were stratified to two subgroups based on the
presence or absence of MOF and infection, and the clin-
ical variables were compared between subgroups. Figure 3
shows that NK cells increased significantly in the infection
subgroup (p = 0.021). Activated effector T cells were sig-
nificantly decreased in the MOF subgroup (p = 0.002)
while the ratio of CD4 +CD25 + CD127low and CD4 +
CD25 +CD127high subsets (CD127low/CD127high) was
significantly increased in the MOF subgroup (p = 0.02).
There was no difference in other lymphocytes subsets
between subgroups. Patients in the MOF subgroup
were older (p = 0.04) and had higher APACHEIIscores
Table 1 Selected baseline characters of the study patientsabc











Amylase(IU) at admission 720(349.5–1581.25)
CRP(mg/L) at admission 73.59 ± 80.44
Comorbidities 17(35.42%)
APACHEIIscores at enrollment 5.19 ± 3.66
SOFA scores at enrollment 2(1–3)
Balthazar scores at enrollment 2(2–3.75)
Lymphocyte (%) 16.24 ± 9.60
Lymphocyte subsets
B cell (%) 7.84 ± 5.89
T cell (%) 68.92 ± 9.69
Helper T cell (%) 42.65 ± 11.31
Cytotoxic T cell (%) 23.38 ± 7.46
NK cell (%) 15.49 ± 7.88
Tregs (%) 5.55 ± 1.69
Activated effector T cell (%) 5.62 ± 2.42
CD4+/CD8+ 2.13 ± 1.18
CD127low/high 1.15 ± 0.58
aCategorical variables are presented as count (frequency) and continues variables
as mean (standard deviation) or median (quartiles) depending on the normality
of the data
bCRP: C-reactive protein, APACHE: Acute Physiology and Chronic Health
Evaluation, Tregs: T regular cell
cthe value of the lymphocyte subsets including B cell, T cell, Helper T cell,
Cytotoxic T cell, NK cell is the percentage to total lymphocytes. Whereas the
value of two subsets including Treg cell and activated effector T cell is the
percentage to helper T cell
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(p = 0.001) and CRP (p = 0.04) (Table 2). There were no
associations between LOS and either MOF (rho = 0.084
p = 0.573) or infection (rho = 0.213 p = 0.147).
Multivariate analysis for MOF
Multivariate logistic regression was performed adjusting
for the effects of potentially confounding variables to
predict MOF as a function of activated effector T cells,
CD127low/high, and age. These variables were selected
by investigating the association of all variables in Table 2
with MOF and selecting variables with significant associ-
ations as potential confounders. Using this multivariate
regression model, only the variable, activated effector T
cells (OR = 0.564 p = 0.042 95% CI [0.324, 0.98]), was a
significant negative predictor of MOF (Table 3).
ROC Curve of activated effector T cells in Predicting
non-MOF and APACHEIIscores and CRP in predicting MOF
Figure 4 illustrates the superiority of activated effector T
cells (area under the curve 0.74) in predicting non-MOF.
Activated effector T cells at 6.41% could be used as a
cut-off point to predict non-MOF with a sensitivity of
53.8%, specificity of 90.9%. In contrast, both
APACHEIIand CRP exhibited powerful ability to predict
MOF with areas under the curves of 0.802 and 0.701, re-
spectively, indicating that the former was superior than
the latter based on the ROC curves (Fig. 5).
Discussion
The principle findings of our study are: (1) among per-
ipheral lymphocyte subsets, only activated effector T
cells phenotyped by CD4 + CD25 + CD127high have a
significant negative correlation with MOF and can be
used as a predictor of non-MOF estimation in AP; and
(2) there is a statistically significant association between
NK cells at admission and secondary infection.
AP can present as a severe acute abdominal disease
with a high mortality. Patients with AP can develop an
early-onset phase of SIRS within 2 weeks, and/or an in-
fection phase due to pancreatic necrosis. MOF and/or
infection signal the presence of severe disease, and there
is a high risk of death if both are present [11]. Thus, both
MOF and infection are unfavorable prognostic signs in AP
patients.
In the present study, we did not find correlations be-
tween activated effector T cells and both SOFA scores
and Balthazar scores (r = −0.276 p = 0.058 and r = −0.140
p = 0.342 respectively). In contrast, there were correlations
between activated effector T cells and both APACHE
IIscores and CRP. Furthermore, there were significant dif-
ferences in the level of activated effector T cells among
three subgroups stratified by Revision of Atlanta criteria
(F = 5.26 p = 0.009), and the severe AP patients had the
lowest level of activated effector T cells (5.36% ± 1.31%).
From the result, it was demonstrated that activated ef-
fector T cells enrollment was in accordance with Ranking
criteria, APACHE IIscores and CRP rather than Balthazar
scores and SOFA scores. Balthazar scores based on the
CT findings focus on local complications of AP and it is
hard to reflect the systematic immunology condition. In
terms of SOFA scores, it is not a normal clinical predictor
in assessing severity of AP. considering the potential con-
founding bias caused by accumulative SOFA scores, it was
just utilized for judging whether it was MOF individually
in the present study.
An accurate predictor to prognosis would be helpful
for clinicians by allowing patients with a predicted
Fig. 3 mean NK cells percentage of lymphocytes at admission in
infection group vs non- infection
Table 2 Univariate analysis of selected variables between
subgroups sorting with MOF
MOF (n = 22) Non-MOF (n = 26) P value
Age(years) 55 ± 14.58 46 ± 15.59 0.04
APACHEIIscores 7 ± 3.66 4 ± 2.89 0.001
CRP(mg/L) 100.53 ± 94.38 50.8 ± 59.2 0.04
Tregs (%) 5.51 ± 1.87 5.59 ± 1.56 0.879
Activated effector T cell (%) 4.49 ± 1.5 6.57 ± 2.65 0.002
CD4+/CD8+ 2.2 ± 1.34 2.07 ± 1.04 0.71
CD127low/high 1.35 ± 0.66 0.97 ± 0.44 0.02
CRP C-reactive protein, APACHE Acute Physiology and Chronic Health Evaluation,
Tregs T regular cell, MOF multiple organ failure
Table 3 Multiple logistic regression model for MOF
predictor Frequency of MOF
OR 95%CI P value
age 1.044 0.996–1.094 0.073
Activated effector T cell (%) 0.564 0.324–0.98 0.042
CD127low/high 0.881 0.156–4.977 0.886
MOF multiple organ failure
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Fig. 4 ROC curve of CD4 + CD25 + CD127high cell in predicting non-MOF developing in the progress of acute pancreatitis
Fig. 5 ROC curve of APACHEIIversus CRP in predicting MOF developing in the progress of acute pancreatitis
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severe course to be transferred to an intensive care unit
while patients with a predicted mild course may be
treated in an outpatient setting. Severity scoring systems
such as APACHEIIand laboratory testing such as CRP
have been used to accurately predict an unfavorable out-
come, which we have confirmed in the present study
[12, 13]. However, there has not been a validated, pub-
lished strategy to predict a favorable outcome, which is
important to avoid overtreatment. In the present study,
only a special T cell subset called CD4 +CD25 +CD127high
cells using the cutoff value >6.41% at admission was a sta-
tistically significant negative predictor of AP severity upon
patient presentation to the hospital. Even though this pre-
dictor had a low sensitivity of 53.8%, we believe that the
specificity of such a value is of more clinical importance
than its sensitivity because conservative and supportive
management is the initial care for patients with AP and it
seems unnecessary to apply drastic remedies for those with
higher CD4 +CD25 +CD127high cells. This test’s potential
as a superior predictor of a favorable prognosis will require
confirmation in a larger population.
Lymphocytes play important roles in both adaptive
and innate immune responses. The main function of the
lymphocytic immune response is to mediate and resolve
the nonspecific inflammatory process in AP. CD4+ T
cells may act as co-stimulators for macrophage activation
via antigen presentation and pro-inflammatory cytokine
release as well as through direct cytotoxic effects (on
acini) through Fas ligand expression on CD4+ T cells [14].
In addition, a distinct set of CD4 + CD25 + FOXP3 +
Tregs presenting immunological tolerance and homeosta-
sis have been identified with anti-inflammatory functions
in AP [15]. These cells could bind to multiple effector im-
mune cells and prevent their secretion of cytokines. They
also secrete anti-inflammatory cytokines such as interleu-
kin (IL)-10 and transforming growth factor (TGF)-β.
Tregs have also been reported to restrain SIRS [16]. It was
impossible to purify living Tregs in vivo previously be-
cause of the exclusive intracellular expression of FOXP3
as a critical factor for Tregs function. Recently, CD127
(IL-7 receptor a chain), whose expression was reverse to
FOXP3, was recommended as an marker of Treg and has
confirmed superiority compared to other cell surface
markers [17, 18]. As indicated in previous study, serum
sCD163, a biomarker released from macrophages, was in-
creased in AP, but not associate with disease severity [19].
In present study, we used the sorting strategy of combin-
ing CD4+, CD25+, and CD127low to obtain viable, ex-
pandable Treg cells. There was no significant difference in
Tregs between the two groups statistically, and we also
found the mean number of Tregs as a percentage of
CD4+ T cells was 5.55 ± 1.69%, which was a little lower
than the 6.25 ± 0.26% in healthy people reported in pre-
vious research [18].
Prior studies have come to different conclusions re-
garding variation of Tregs in SIRS or the early phase of
AP. Xue H et al. [20] reported that CD4 + CD25 + Tregs
increased in SIRS and suppressed the excessive inflam-
matory response. In contrast, other investigators have
reported that positive CD4 + CD25+ T cells significantly
declined in a mouse SAP model [8]. Data on Tregs in
humans with AP is limited and our data may be of value
as a reference for future study.
Interestingly, the novel subgroup CD4+CD25+CD127high
cells had predictive value for the development of non-MOF
in this investigation. This subset was previously thought to
be a contaminant interfering with the suppressive function of
Tregs and was neglected previously.[18] However, research
by Michel L indicates that this specific population in multiple
sclerosis (MS) appears more proliferative and secretes more
interferon-γ (IFN-γ) and interleukin-2 (IL-2), both pro-
inflammatory cytokines, than healthy individuals [21].
Similar observation has been made in CD4 + CD25 +
CD127high cells infiltrating rejected human allografts, in
which allo-specific CD4 + CD25 + CD127high cells were
able to secrete effector cytokines such as tumor necrosis
factor-α (TNF-α) and IFN-γ [22]. The ratio of CD127low/
high also was statistically different in subgroups with and
without MOF, but had no correlation with MOF in our
multivariate regression model. Thus, CD4 + CD25 +
CD127high cells counts may be the sole factor which are
associated with MOF estimation, and it is postulated
that increment of CD4+CD25 +CD127high cells have a pro-
tective function to reflect the progress of AP independent of
Tregs. The exact mechanism of CD4+CD25 +CD127high
cell function in the setting of AP needs further study.
NK cells with phenotype marker CD3-CD16 + CD56+
are the type of cytotoxic lymphocytes critical to the in-
nate immune system and secrete TNF-α and IFN-γ to
control viral infection [23]. Dabrowski A et al. [24]
found a dramatic depletion of peripheral NK cells in
SAP compared to MAP and control, which indicates that
there may be a correlation between NK cells and severity
of AP. Our research further found that a lower number
of NK cells at admission were associated with the develop-
ment of secondary infection in AP patients. Since most
pathogens causing secondary pancreatic infection are
Gram-negative bacteria such as Escherichia coli originat-
ing from gut [25], we hypothesize that once circulating
NK cells run into Gram-negative bacteria in a primary in-
fection, they acquire memory function features which are
a hallmark of T and B cells belonging to the adaptive im-
mune system [26]. The memory-like, circulating NK cells
then migrate into the pancreas at the early onset of AP
and trigger a rapid immune response to the same antigen
encountered again. In any case, patients with lower NK
cells at admission may have a high risk of developing sec-
ondary infection in AP.
Wang et al. World Journal of Emergency Surgery  (2017) 12:7 Page 7 of 9
Limitations
Specific limitations need to be considered when inter-
preting results of our study. First, the number of study
patients included (n = 48) and infection group (n = 3)
was low. Furthermore, sepsis in the secondary progres-
sion of AP also triggers MOF which is more likely to
happen due to SIRS in the first phase. The selection bias
without intent may affect extrapolation of our outcomes,
especially regarding the predictor role of activated ef-
fector T cells to non-MOF. Nonetheless, statistical sig-
nificance was achieved for several analyses suggesting
that these relationships could be clinically relevant. Sec-
ond, the observational nature of this study indicated that
relationships between dependent and independent vari-
ables are associations, and not cause and effect. Third, a
separate test might be needed in different phases of the
disease because of the essential dynamic progress of im-
mune function during the development of AP. The
present study did not dynamically investigate the immune
function. Therefore, it can’t reflect comprehensive im-
munological fluctuation.
Conclusion
Increased peripheral CD4 +CD25 + CD127high cells, whose
physiological role in the early phase of AP is unclear in the
early phase of AP, appear to be associated with a good
(non-MOF) prognosis. In addition, patients with lower NK
cells at admission may have a higher risk of developing
secondary infection in AP. Further study is needed to
confirm these observations.
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